Literature DB >> 32428649

In utero exposure to arsenite contributes to metabolic and reproductive dysfunction in male offspring of CD-1 mice.

Karina F Rodriguez1, Namya Mellouk1, Erica K Ungewitter1, Barbara Nicol1, Chang Liu1, Paula R Brown1, Cynthia J Willson2, Humphrey H-C Yao3.   

Abstract

In utero exposure to arsenite (iAs) is known to increase disease risks later in life. We investigated the effect of in utero exposure to iAs in the drinking water on metabolic and reproductive parameters in male mouse offspring at postnatal and adult stages. Pregnant CD-1 mice were exposed to iAs (as sodium arsenite) in the drinking water at 0 (control), 10 ppb (EPA standard for drinking water), and 42.5 ppm (tumor-inducing dose in mice) from embryonic day (E) 10-18. At birth, pups were fostered to unexposed females. Male offspring exposed to 10 ppb in utero exhibited increase in body weight at birth when compared to controls. Male offspring exposed to 42.5 ppm in utero showed a tendency for increased body weight and a smaller anogenital distance. The body weight in iAs-exposed pups continued to increase significantly compared to control at 3 weeks and 11 weeks of age. At 5 months of age, iAs-exposed males exhibited greater body fat content and glucose intolerance. Male offspring exposed to 10 ppb in utero had higher circulating levels of leptin compared to control. In addition, males exposed to 42.5 ppm in utero exhibited decreased total number of pups born compared to controls and lower average number of litters sired over a six-month period. These results indicate that in utero exposure to iAs at either human relevant concentration or tumor-inducing concentration is a potential cause of developmental origin of metabolic and reproductive dysfunction in adult male mice. Published by Elsevier Inc.

Entities:  

Keywords:  Arsenic; Developmental origins of health and diseases; In utero exposure; Metabolic syndromes; Obesity

Mesh:

Substances:

Year:  2020        PMID: 32428649      PMCID: PMC7323850          DOI: 10.1016/j.reprotox.2020.05.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  40 in total

1.  The involvement of hypophyseal-gonadal and hypophyseal-adrenal axes in arsenic-mediated ovarian and uterine toxicity: modulation by hCG.

Authors:  Sandip Chattopadhyay; Debidas Ghosh
Journal:  J Biochem Mol Toxicol       Date:  2010 Jan-Feb       Impact factor: 3.642

2.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.

Authors:  Michael P Waalkes; Jerrold M Ward; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2003-01-01       Impact factor: 4.219

3.  Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; Jerrold M Ward; Don A Delker; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2010-10-11       Impact factor: 4.849

4.  Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism.

Authors:  Michelle Welsh; Philippa T K Saunders; Mark Fisken; Hayley M Scott; Gary R Hutchison; Lee B Smith; Richard M Sharpe
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Arsenic abrogates the estrogen-signaling pathway in the rat uterus.

Authors:  Aniruddha Chatterjee; Urmi Chatterji
Journal:  Reprod Biol Endocrinol       Date:  2010-07-02       Impact factor: 5.211

6.  Anogenital distance and penile length in infants with hypospadias or cryptorchidism: comparison with normative data.

Authors:  Ajay Thankamony; Ngee Lek; Dan Carroll; Martyn Williams; David B Dunger; Carlo L Acerini; Ken K Ong; Ieuan A Hughes
Journal:  Environ Health Perspect       Date:  2013-12-06       Impact factor: 9.031

7.  Maternal arsenic exposure, arsenic methylation efficiency, and birth outcomes in the Biomarkers of Exposure to ARsenic (BEAR) pregnancy cohort in Mexico.

Authors:  Jessica E Laine; Kathryn A Bailey; Marisela Rubio-Andrade; Andrew F Olshan; Lisa Smeester; Zuzana Drobná; Amy H Herring; Miroslav Stýblo; Gonzalo G García-Vargas; Rebecca C Fry
Journal:  Environ Health Perspect       Date:  2014-10-17       Impact factor: 9.031

8.  Prenatal Arsenic Exposure and Birth Outcomes among a Population Residing near a Mining-Related Superfund Site.

Authors:  Birgit Claus Henn; Adrienne S Ettinger; Marianne R Hopkins; Rebecca Jim; Chitra Amarasiriwardena; David C Christiani; Brent A Coull; David C Bellinger; Robert O Wright
Journal:  Environ Health Perspect       Date:  2016-02-09       Impact factor: 9.031

Review 9.  Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review.

Authors:  Elizabeth A Maull; Habibul Ahsan; Joshua Edwards; Matthew P Longnecker; Ana Navas-Acien; Jingbo Pi; Ellen K Silbergeld; Miroslav Styblo; Chin-Hsiao Tseng; Kristina A Thayer; Dana Loomis
Journal:  Environ Health Perspect       Date:  2012-08-10       Impact factor: 9.031

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  2 in total

1.  Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus.

Authors:  Kamakshi Mehta; Kamlesh Kumar Pandey; Balpreet Kaur; Pushpa Dhar; Saroj Kaler
Journal:  Psychopharmacology (Berl)       Date:  2021-05-28       Impact factor: 4.530

Review 2.  Obesity II: Establishing causal links between chemical exposures and obesity.

Authors:  Jerrold J Heindel; Sarah Howard; Keren Agay-Shay; Juan P Arrebola; Karine Audouze; Patrick J Babin; Robert Barouki; Amita Bansal; Etienne Blanc; Matthew C Cave; Saurabh Chatterjee; Nicolas Chevalier; Mahua Choudhury; David Collier; Lisa Connolly; Xavier Coumoul; Gabriella Garruti; Michael Gilbertson; Lori A Hoepner; Alison C Holloway; George Howell; Christopher D Kassotis; Mathew K Kay; Min Ji Kim; Dominique Lagadic-Gossmann; Sophie Langouet; Antoine Legrand; Zhuorui Li; Helene Le Mentec; Lars Lind; P Monica Lind; Robert H Lustig; Corinne Martin-Chouly; Vesna Munic Kos; Normand Podechard; Troy A Roepke; Robert M Sargis; Anne Starling; Craig R Tomlinson; Charbel Touma; Jan Vondracek; Frederick Vom Saal; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.